Maria J. Almela
GlaxoSmithKline R&D
Madrid, MD, Spain
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High-Content Phenotypic Screen of a Focused TCAMS Drug Library Identifies Novel Disruptors of the Malaria Parasite Calcium Dynamics.
Journal: ACS chemical biology
Published: October 05, 2021
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against Plasmodium falciparum Malaria Parasites.
Journal: Journal of medicinal chemistry
Published: October 01, 2019
Correction to The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
Journal: Journal of medicinal chemistry
Published: November 23, 2017
The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
Journal: Journal of medicinal chemistry
Published: August 15, 2017
A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents.
Journal: Malaria journal
Published: April 07, 2016
Transmission-Blocking Potential of MEFAS, a Hybrid Compound Derived from Artesunate and Mefloquine.
Journal: Antimicrobial agents and chemotherapy
Published: September 10, 2015
Red blood cells derived from peripheral blood and bone marrow CD34⁺ human haematopoietic stem cells are permissive to Plasmodium parasites infection.
Journal: Memorias do Instituto Oswaldo Cruz
Published: June 21, 2013
Design, synthesis, and in vitro activity of novel 2'-O-substituted 15-membered azalides.
Journal: Journal of medicinal chemistry
Published: March 03, 2012
Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay.
Journal: PloS one
Published: October 27, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026